Ending TB Is Within Reach — So Why Are Millions Still Dying?
Tuberculosis has passed Covid as the top infectious disease killer, despite new medicines and better diagnostic tools. (Source: NYT Health)
Source: NYT Health - November 6, 2023 Category: Consumer Health News Authors: Stephanie Nolen and Natalija Gormalova Tags: Tuberculosis Vaccination and Immunization Drugs (Pharmaceuticals) Tests (Medical) Clinical Trials Medicine and Health Developing Countries Drug Resistance (Microbial) Infections Africa Ghana your-feed-science your-feed-healthcare Source Type: news
Africa: TB Vaccine - WHO Expert Explains Why It's Taken 100 Years for a Scientific Breakthrough, and Why It's Such a Big Deal
[The Conversation Africa] The BCG vaccine for TB has been used for 100 years. It is largely effective for children under five, but less so in older people and can't be used on patients who have certain medical conditions. Today we're the closest we've ever been to discovering a vaccine that might replace or complement it. Charles Shey Wiysonge, the World Health Organization's Regional Adviser for Immunisation, discusses the latest developments in the fight against one of the world's deadliest diseases. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - October 31, 2023 Category: Infectious Diseases Tags: Africa Health and Medicine Tuberculosis Source Type: news
First malaria vaccine slashes early childhood deaths
In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. Hundreds of thousands of children are born annually in the parts of Ghana, Kenya, and Malawi included in the analysis, for which WHO revealed the final data on 20 October at the annual meeting of the American Society of Tropical M...
Source: ScienceNOW - October 24, 2023 Category: Science Source Type: news
Three Tuberculosis Vaccines Reach Final Stage of Development Three Tuberculosis Vaccines Reach Final Stage of Development
Around 15 vaccine candidates are being developed in the battle against tuberculosis to compensate for the poor efficacy of the Bacillus Calmette-Gu érin vaccine.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 11, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Immunity-enhancing cocktail protects mice against multiple hospital germs
Some people in hospital die not from the illness or accident that got them admitted but from germs they catch once there. In the United States alone, there are hundreds of thousands of hospital-acquired infections each year, leading to tens of thousands of deaths. Seeking to lower this toll, researchers have now come up with an
immune-boosting cocktail that increases the survival
of mice exposed to the microbes responsible.
The three-compound formulation, which the researchers unusually refer to as a vaccine, provided up to 28 days of protection from the notorious hospital bacterium
Pseudomonas aerugin...
Source: ScienceNOW - October 4, 2023 Category: Science Source Type: news
South Africa: A UN Meeting On TB Is At Best a Means to More Important Ends
[spotlight] In 2018 the first findings from a landmark tuberculosis (TB) vaccine trial were published in the New England Journal of Medicine. The experimental vaccine, called M72, was found to be roughly 50% effective in preventing pulmonary TB disease. It was the most promising finding for a new TB vaccine since the development of the BCG vaccine a century ago. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - September 14, 2023 Category: Infectious Diseases Tags: Health and Medicine South Africa Southern Africa Tuberculosis Source Type: news
TB Preventive Treatment: the Need for Choice
The progress made in HIV prevention is nothing short of a global success story. It is time that TB caught up to HIV. Medicine is simply too advanced for us to tolerate how one disease can be beaten back yet another continues to flourish. Credit: Jeffrey Moyo/IPS. By Violet ChihotaJOHANNESBURG, Jul 26 2023 (IPS) Before COVID-19 came along, the two most lethal infectious diseases were HIV and tuberculosis (TB). Even though HIV still lingers, with 1.5 million people contracting the infection every year, epidemiologists point to the availability of many HIV prevention options as a primary reason for the decreasing caseload.
Ac...
Source: IPS Inter Press Service - Health - July 26, 2023 Category: International Medicine & Public Health Authors: Violet Chihota Tags: Africa Headlines Health Poverty & SDGs tuberculosis (TB) Source Type: news
SII manufactured BCG vaccine gets export nod to treat bladder cancer
The Serum Institute of India has been granted permission to export its BCG vaccine to Canada for the treatment of bladder cancer, following a request from the director, Prakash Kumar Singh. BCG as immunotherapy is a live freeze-dried preparation derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin) and is sold in 40mg and 80mg presentations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2023 Category: Pharmaceuticals Source Type: news
Tuberculosis vaccine to enter final trials, raising hopes of saving millions
If the next steps are successful, M72 would be the first new vaccine in a century to target tuberculosis, a disease that killed 1.6 million people in 2021. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 30, 2023 Category: Consumer Health News Authors: Shera Avi-Yonah Source Type: news
TB vaccine candidate to enter final trial, raising hopes of saving millions
If the next steps are successful, M72 would be the first new vaccine in a century to target tuberculosis, a disease that killed 1.6 million people in 2021. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - June 30, 2023 Category: Consumer Health News Authors: Shera Avi-Yonah Source Type: news
South Africa: Funding Secured for Massive TB Vaccine Trial
[spotlight] A massive and much-anticipated phase 3 trial of an experimental tuberculosis (TB) vaccine is set to proceed after funding for it has been secured from two large philanthropies. Wellcome and the Bill & Melinda Gates Foundation (BMGF) Wednesday announced they'd be investing a combined $550 million into the trial - around $150 million from Wellcome and the remaining from the Bill & Melinda Gates Medical Research Institute, a nonprofit subsidiary of the BMGF. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2023 Category: Infectious Diseases Tags: Health and Medicine NGOs and Civil Society South Africa Southern Africa Tuberculosis Source Type: news
Africa: Wellcome and Gates Foundation to Fund Late-Stage Development of TB Vaccine Candidate That Could Be First in 100 Years If Proven Effective
[Gates Foundation] London and Seattle -- TB is one of the world's deadliest diseases, killing about 4,300 people per day, mostly those living in povert (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2023 Category: Infectious Diseases Tags: Africa External Relations Health and Medicine International Organizations and Africa Tuberculosis Source Type: news
South Africa: South Africa Included in Gates-Led Clinical Trial of New TB Vaccine Hailed As Potential Game-Changer
[Daily Maverick] A Phase 3 clinical trial for M72, a new candidate vaccine against pulmonary tuberculosis will be conducted in South Africa. The head of Global Health at the Bill & Melinda Gates Foundation, Dr Trevor Mundel, said this week that they were very optimistic that it would be an effective and safe vaccine. However, this will be determined by the success of the Phase 3 trials. (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - June 29, 2023 Category: Infectious Diseases Tags: External Relations Health and Medicine International Organizations and Africa South Africa Southern Africa Tuberculosis Source Type: news
Wellcome Trust, Gates Foundation Fund First New TB Vaccine in 100 Years
The last time the TB vaccine had an update Warren Harding was president. For the first time in over a century, a new tuberculosis vaccine is entering large-scale critical trials, courtesy of a more than half-billion dollar contribution from two of the world’s leading medical charities: The Bill &…#tb #warrenharding #wellcometrust #gatesfoundations #m72 #africa #southeastasia #gatesfoundation #wellcome #offshelfits (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2023 Category: Consumer Health News Source Type: news
Gates Foundation and Wellcome fund $550mn trial of first new TB vaccine for 100 years
Large-scale study will test GSK’s jab in 26,000 people in Africa and south-east Asia (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 28, 2023 Category: Pharmaceuticals Source Type: news
